Chondroitin sulfate: A potential biodegradable carrier for colon-specific drug delivery

https://doi.org/10.1016/0378-5173(92)90054-6Get rights and content

Abstract

Chondroitin sulfate, a soluble mucopolysaccharide utilized as a substrate by the bacteroid inhabitants of the colon, was cross-linked and formulated in a matrix form with indomethacin as a drug marker. Three levels of cross-linkage were used. Cross-linkage was characterized qualitatively by IR spectral analysis and by UV absorbance shifts in hydroalcoholic solutions; it was also characterized quantitatively by comparing the amount of methylene blue remaining after adsorption (at equilibrium) onto the cross-linked product vs that remaining after adsorption onto untreated Chondroitin. The indomethacin release kinetics from the various formulations was analyzed in phosphate-buffered saline (PBS) with and without rat caecal content at 37°C under a CO2 atmosphere. In separate experiments the caecal content was sonicated to cause lysis of the bacterial cell membranes. The drug release profiles indicated a constant rate of biodegradation in the presence of rat caecal content, and diffusion-driven release from the matrix's surface area in PBS control. Prolonged incubation in PBS with rat caecal content increased drug release, and by 28 h the released indomethacin levels were significantly higher than those in the PBS controls. The maximal cumulative percent release values for the PBS controls were: 30.1 ± 10.0, 19.7 ± 15.0, 9.0 ± 4.1 for the three levels of cross-linkage of the Chondroitin sulfate carriers, respectively, while those for the caecal content media were 71.0 ± 19.0, 48.7 ± 35.0, and 22.5 ± 7.9, respectively. It was concluded that the indomethacin release from these systems was dependent upon the biodegradation action of the caecal content. The linear correlation between the degree of cross-linkage and the amount of drug released in the presence of caecal content suggests that drug release in the colon can be controlled by adjusting the relative amounts of the variously cross-linked Chondroitin sulfate formulations in the matrices.

References (28)

  • K. Ikesue et al.

    Degradation of proteins by enzymes of the gastrointestinal tract

  • U. Klotz.

    Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid

    Clin. Pharmacokinet.

    (1985)
  • C. Larsen et al.

    Stability of ketoprofen-dextran ester prodrugs in homogenates of various segments of the pig tract

    Acta Pharm. Nord.

    (1991)
  • C. Larsen et al.

    Macro-molecular prodrugs. XVI: Colon-targeted delivery — comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal tract

    Pharm. Res.

    (1989)
  • Cited by (137)

    • Microbial, animal, and biotechnologically originated polysaccharides

      2023, Polysaccharide Hydrogels for Drug Delivery and Regenerative Medicine
    • Chondroitin sulfate-curcumin micelle with good stability and reduction sensitivity for anti-cancer drug carrier

      2021, Materials Letters
      Citation Excerpt :

      Chondroitin sulfate (ChS) is a kind of natural polymer polysaccharide extracted from animal tissues. It is composed of alternating glucuronic acid and N-acetylgalactosamine, has biocompatibility and hydrophilicity [8]. Most importantly, ChS is able to specifically bind to the over-expressed glycoprotein CD44 receptor on cancer cells, thereby enabling active targeting of tumors [9].

    • Development and characterization of pH-sensitive chondroitin sulfate-co-poly(acrylic acid) hydrogels for controlled release of diclofenac sodium

      2021, Journal of Saudi Chemical Society
      Citation Excerpt :

      Chondroitin sulfate is a polysaccharide polymer used in the preparation of different dosage form to manage different serious disorders. Chondroitin sulfate is easily obtained from cartilage of animals; its chemical composition contains D-glucuronic acid interconnected to N-acetyl-D-galactosamide [11]; and it gives protection to connective tissues by controlling water content, hence is used for long periods of time to manage serious disorders like osteoarthritis, thrombosis and atherosclerosis [12,13]. Active functional groups of chondroitin sulfate like COO- and -SO3- enable this biopolymer to be a possible applicant to achieve greater water absorption by hydrogels [14].

    • Applications of Polymers in Colon Drug Delivery

      2020, Applications of Polymers in Drug Delivery
    View all citing articles on Scopus
    View full text